Organizations commend House Committee on Oversight and Accountability for hearing on PBM tactics.
NACDS President and CEO Steven C. Anderson released the following statement today in anticipation of a legislative markup on May 24 by the U.S. House of Representatives Committee on Energy and Commerce:
Implementation of NYRx New York Medicaid pharmacy benefit celebrated.
Study reflects “NACDS 2023” focus on adding value to NACDS members’ innovation of health and wellness in the pharmacy and beyond.
NACDS is lauding legislation introduced by U.S. Senators Peter Welch (D-VT) and Roger Marshall (R-KS) to crack down on tactics by which “pharmaceutical benefit manipulator” middlemen maximize profits at the expense of patients, pharmacies, and others.
NYRx puts patients over PBMs in the state’s Medicaid pharmacy benefit.
The Drug Price Transparency in Medicaid Act will protect patients, pharmacies, and others from middlemen tactics that drive up prescription drug prices.
The decision offers hope for the ability of pharmacies to continue to meet patients’ needs in Washington State and across the nation.
Calls on the Center for Medicare and Medicaid Innovation to integrate pharmacies and pharmacists into value-based programs and alternative payment models to accelerate mission toward better outcomes and lower costs.
Pharmacy groups applaud this victory for pharmacies and patient access to care .
